A critical breakthrough in cancer research is occurring with the use of VHH fragments to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in various types of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research